UNIGE document Scientific Article
previous document  unige:45240  next document
add to browser collection
Title

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial

Authors
Hess, Viviane
Salzberg, Marc
Borner, Markus
Morant, Rudolf
Ludwig, Christian
Herrmann, Richard
Published in Journal of Clinical Oncology. 2003, vol. 21, no. 1, p. 66-8
Abstract Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine, the current standard treatment for advanced pancreatic carcinoma (APC). In this study, we investigated the addition of capecitabine to gemcitabine treatment for patients with APC.
Keywords AgedAntineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic useDeoxycytidine/administration & dosage/adverse effects/analogs & derivativesFemaleFluorouracil/analogs & derivativesHumansMaleMaximum Tolerated DoseMiddle AgedPancreatic Neoplasms/drug therapy/mortalitySurvival RateSwitzerland/epidemiology
Identifiers
PMID: 12506172
Full text
Article (Published version) (52 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://jco.ascopubs.org/content/21/1/66.long
Structures
Research group Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format)
HESS, Viviane et al. Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. In: Journal of Clinical Oncology, 2003, vol. 21, n° 1, p. 66-8. https://archive-ouverte.unige.ch/unige:45240

142 hits

0 download

Update

Deposited on : 2015-01-14

Export document
Format :
Citation style :